Geistlich Pharma AG
Geistlich Pharma AG, headquartered in Switzerland and founded in 1851, is a pioneering leader in dental biomaterials, leveraging over 170 years of expertise in collagen and regenerative medicine. The company has successfully positioned itself at the forefront of the Dental Soft-Tissue Regeneration market, a testament to its relentless focus on innovative solutions for the regeneration of bone, cartilage, and soft tissues. This specialization is underscored by its global reputation for providing reliable and effective products that are widely used in periodontal treatment, implantology, and oral surgery across more than 60 countries. In the specific domain of dental soft-tissue regeneration, Geistlich offers a core line of specialized collagen matrices. Key products include Geistlich Mucograft®, a matrix for open and submerged healing to cover recession defects and gain keratinized tissue; Geistlich Mucograft® Seal, recommended for covering extraction sockets during Ridge Preservation; and Geistlich Fibro-Gide®, optimized for submerged healing to thicken soft tissue around teeth, implants, and under pontics. The strategic acquisition of LYNCH Biologics further strengthens their commitment to regenerative medicine. By focusing on scientific evidence and continuous research and development, Geistlich Pharma provides essential regenerative infrastructure to drive predictable clinical outcomes in complex dental procedures.
Latest Market Research Report on Dental Soft Tissue Regeneration Download PDF Brochure Now
Institut Straumann AG
Institut Straumann AG is a globally recognized Swiss multinational company and a leading player in the dental industry, specializing in dental implantology, restorative dentistry, and oral tissue regeneration. Founded in 1954, Straumann’s core strategy includes a strong commitment to the dental soft-tissue regeneration market, offering a comprehensive and innovative portfolio designed to enhance healing and restore lost tissues for patients with periodontal disease. The company’s products are renowned for being fabricated from superior quality materials, supporting both reliability and safety during surgical procedures. Straumann’s tissue regeneration products are extensively used to prevent tooth and bone loss, demonstrating the company’s dedication to a holistic approach to patient care. This portfolio features advanced biomaterials, including various tissue grafts and collagen-based membranes, which are crucial components in modern regenerative surgical protocols. Straumann is distinguished by its thorough clinical product testing and ongoing, extensive implant research, often collaborating with well-known research institutes and universities. By continuously focusing on product innovation, clinical evidence, and various growth strategies, Institut Straumann AG maintains its leading position, providing essential solutions that drive advancements in the soft tissue component of complex oral procedures worldwide.
DENTSPLY Sirona
DENTSPLY Sirona is an American global leader in dental products and technologies, established through the 2016 merger of DENTSPLY International (founded 1899) and Sirona Dental Systems. The company operates across numerous segments, including consumables, equipment, and technology, maintaining a prominent position in the dental soft-tissue regeneration market through its regenerative brand, Symbios®. Symbios provides a diverse array of solutions tailored for bone and soft tissue generation, particularly in periodontics, oral surgery, and implant dentistry. The company’s product line includes GBR (Guided Bone Regeneration) and GTR (Guided Tissue Regeneration) membranes and allograft solutions. Specifically for soft tissue, DENTSPLY Sirona offers the Symbios® Allograft and Dermis Portfolio, which features Symbios PerioDerm® Acellular Dermis Matrix, a product used explicitly to treat facial recession defects. The portfolio also includes various collagen membranes, such as the Symbios OsteoShield Collagen Resorbable Membrane (Type-1 bovine collagen) and the Symbios Pre-Hydrated Collagen Dental Membrane (purified whole collagen tissue from bovine pericardium), which are vital barrier membranes for both bone and soft tissue generation procedures. By integrating advanced digital dentistry tools with its regenerative material offerings, DENTSPLY Sirona ensures comprehensive solutions for enhanced clinical efficiency and improved patient outcomes globally.
ZimVie Inc.
ZimVie Inc. is a U.S.-based medical technology company that was spun off from Zimmer Biomet, positioning itself as a formidable competitor in the dental implant and regenerative solutions market. The company’s core focus is on providing a comprehensive product portfolio that addresses critical aspects of dental care, including surgical, restorative, and regenerative needs. ZimVie’s presence in the soft tissue regeneration segment is anchored by its suite of advanced biomaterials. These Regenerative products are designed to be top-tier solutions for both bone and tissue regeneration, which are essential for effective dental reconstructions. The portfolio utilizes various cutting-edge materials, including allografts, xenografts, and synthetic substitutes, which are essential for effective dental reconstructions. This offering caters to diverse patient needs and complex surgical requirements in the dental field. By integrating these high-quality regenerative solutions with its other offerings, such as digital dentistry and prosthetic components, ZimVie streamlines dental workflows. This commitment to combining innovative technologies and specialized care underscores ZimVie’s market influence in the sophisticated arena of dental regenerative medicine, contributing significantly to improved patient outcomes and surgical precision worldwide.
Nobel Biocare (Danaher Corporation)
Nobel Biocare, a significant brand within the Danaher Corporation’s global conglomerate, is a world leader in dental implants and is deeply committed to providing safe and reliable regenerative solutions for Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) procedures. The company’s regenerative product portfolio is specifically designed for ease of use and effectiveness, aiming to be a trusted partner for dental professionals. In the soft tissue segment, Nobel Biocare offers a comprehensive range of products, including various soft tissue matrices, barrier membranes, and bone grafts. Key soft tissue products include Cytoplast MicroDerm™ Allogenic acellular dermal matrix and membranes like creos™ xenoprotect, which is their highest-selling resorbable collagen membrane, and the Cytoplast™ RTM Collagen Membrane. These products are vital for managing soft tissue in procedures such as covering recession defects and GTR. By offering an extensive range of these products, coupled with fixation systems and specialized wound dressings (creos™ absorbable collagen dental wound dressings), Nobel Biocare provides full coverage for all regeneration needs. The brand’s scientific-first approach ensures that its regenerative solutions remain at the forefront of clinical practice.
BioHorizons
BioHorizons, founded in 1994 and headquartered in the U.S., is a major player in the dental industry, recognized as one of the fastest-growing companies in dental implants and biologics. The company is committed to developing evidence-based and scientifically-proven products, which extend into the field of tissue regeneration. BioHorizons provides a comprehensive portfolio of dental implants and tissue regenerative materials used for bone grafting and related surgical procedures. Their dedication to advancing soft tissue integration is exemplified by their proprietary Laser-Lok® surface technology, which features laser-etched channels scientifically proven to promote healthy soft tissue attachment to the implant, a critical factor for long-term implant success and aesthetics. Furthermore, BioHorizons cemented its position in the regenerative market by landing its first global licensing deal for a regenerative collagen medical device with Orthocell Ltd. By focusing on science, innovation, and high-quality products, BioHorizons provides essential, evidence-based solutions that enhance soft tissue outcomes in implant dentistry, enabling customers to confidently achieve superior results.
Henry Schein, Inc.
Henry Schein, Inc., an American company founded in 1932, is one of the world’s largest providers of healthcare products and solutions, and a major enabler in the Dental Soft-Tissue Regeneration market. The company is recognized as a top three player in this market, not primarily as a manufacturer, but as the world’s largest distributor of healthcare products and services. Operating in 32 countries, Henry Schein provides a vast range of dental biomaterials, including regenerative materials, dental implants, and bone grafts, through its extensive global distribution network. This efficient service model ensures that high-quality regenerative materials, which are essential for soft tissue augmentation and healing, are readily accessible to office-based healthcare professionals, including DSOs and independent clinics, worldwide. Henry Schein’s influence is derived from its scale, its ability to supply a diverse product line from numerous manufacturing partners, and its consistent recognition as a leading supplier of technology and value-added services. By serving as a critical link in the supply chain for premium dental biomaterials and digital dentistry solutions, Henry Schein significantly shapes the adoption and utilization of cutting-edge restorative and regenerative products in the global dental healthcare industry.
Latest Market Research Report on Dental Soft Tissue Regeneration Download PDF Brochure Now